We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
-2.88%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$242M
AUM Growth
+$8.86M
Cap. Flow
+$14.9M
Cap. Flow %
6.16%
Top 10 Hldgs %
34.33%
Holding
60
New
15
Increased
15
Reduced
14
Closed
11

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$5.74M
2
CI icon
Cigna
CI
+$4.68M
3
NVO
Novo Nordisk
NVO
+$4.62M
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$4.62M
5
MDT icon
Medtronic
MDT
+$3.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$5.91M
2
LLY icon
Eli Lilly
LLY
+$4.5M
3
BDX icon
Becton Dickinson
BDX
+$4.4M
4
BMY icon
Bristol-Myers Squibb
BMY
+$4.37M
5
MOH icon
Molina Healthcare
MOH
+$3.98M

Sector Composition

Rank Sector Weight
1 Healthcare 93.04%
2 Energy 1.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CI icon
26
Cigna
CI
$73.3B
$4.79M 1.98%
+20,000
New +$4.68M
BAX icon
27
Baxter International
BAX
$13.9B
$4.65M 1.92%
60,000
-15,000
-20% -$1.26M
IQV icon
28
IQVIA
IQV
$39.8B
$4.62M 1.91%
20,000
+5,000
+33% +$1.18M
MDT icon
29
Medtronic
MDT
$116B
$3.88M 1.6%
+35,000
New +$3.7M
OPCH icon
30
Option Care Health
OPCH
$3.57B
$3.71M 1.53%
130,000
– –
CYH icon
31
Community Health Systems
CYH
$410M
$3.56M 1.47%
300,000
+50,232
+20% +$611K
AMED
32
DELISTED
Amedisys
AMED
$3.45M 1.42%
+20,000
New +$2.99M
LHCG
33
DELISTED
LHC Group LLC
LHCG
$3.37M 1.39%
+20,000
New +$2.67M
ACHC icon
34
Acadia Healthcare
ACHC
$2.95B
$3.28M 1.35%
+50,000
New +$2.9M
ABBV icon
35
AbbVie
ABBV
$440B
$3.24M 1.34%
20,000
-20,000
-50% -$2.91M
SGRY icon
36
Surgery Partners
SGRY
$2.01B
$3.14M 1.3%
+57,020
New +$2.82M
SEM
37
DELISTED
Select Medical
SEM
$3.12M 1.29%
241,280
+74,240
+44% +$980K
BMRN icon
38
BioMarin Pharmaceuticals
BMRN
$13.6B
$3.08M 1.27%
40,000
– –
NVST icon
39
Envista
NVST
$4.61B
$2.92M 1.21%
+60,000
New +$2.77M
LLY icon
40
Eli Lilly
LLY
$1.09T
$2.86M 1.18%
10,000
-17,500
-64% -$4.5M
INCY icon
41
Incyte
INCY
$24.5B
$2.78M 1.15%
+35,000
New +$2.55M
GH icon
42
Guardant Health
GH
$22.2B
$2.65M 1.09%
40,000
+15,000
+60% +$1.03M
SGEN
43
DELISTED
Seagen Inc. Common Stock
SGEN
$2.52M 1.04%
+17,500
New +$2.37M
GRFS
44
Grifois
GRFS
$5.4B
$2.34M 0.96%
+200,000
New +$2.3M
CAH icon
45
Cardinal Health
CAH
$54.5B
$2.27M 0.94%
40,000
-20,000
-33% -$1.07M
NBIX icon
46
Neurocrine Biosciences
NBIX
$15.9B
$2.11M 0.87%
+22,500
New +$1.91M
NTRA icon
47
Natera
NTRA
$45.5B
$2.03M 0.84%
50,000
+25,000
+100% +$1.5M
MRNA icon
48
Moderna
MRNA
$25.4B
$1.72M 0.71%
+10,000
New +$1.68M
BNTX icon
49
BioNTech
BNTX
$23.3B
$1.71M 0.7%
+10,000
New +$1.68M
BDX icon
50
Becton Dickinson
BDX
$50B
– –
-17,938
Closed -$4.4M
1
2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return
CIP
Castlefield Investment Partners Manchester $131M AUM

Sivik Global Healthcare's Q1 2022 Portfolio in Review

As of Q1 2022, Sivik Global Healthcare held 60 positions worth $242M, up 3.8% from $233M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Sivik Global Healthcare deployed $14.9M of net new capital in Q1 2022, opening 15 new positions and adding to 15 existing holdings. Its largest new stake was Centene: 70,000 shares worth $5.89M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 95% a quarter earlier, followed by Energy.

On the sell side, the largest reduction was Eli Lilly, an estimated $4.5M trimmed.

  • Sivik Global Healthcare's largest Q1 2022 buy was Centene: 70,000 shares worth $5.89M.
  • Sivik Global Healthcare added most to State Street SPDR S&P Biotech ETF in Q1 2022, an estimated $4.62M increase.
  • Sivik Global Healthcare's biggest Q1 2022 reduction was Eli Lilly, cutting an estimated $4.5M.
  • Sivik Global Healthcare fully exited Pfizer in Q1 2022, selling an estimated $5.91M.
  • Sivik Global Healthcare's ten largest holdings make up 34% of its $242M portfolio in Q1 2022.
  • Sivik Global Healthcare opened 15 new positions and closed 11 in Q1 2022.
  • Sivik Global Healthcare's portfolio value rose 3.8% quarter-over-quarter to $242M.

Based on Sivik Global Healthcare's 13F filing for Q1 2022, filed 9 May 2022.